Balyasny Asset Management
PLSE icon

Balyasny Asset Management’s Pulse Biosciences PLSE Stock Holding History

Balyasny Asset Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.72M Buy
+265,164
New +$4.89M 0.01% 1308

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Balyasny Asset Management's PLSE Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Pulse Biosciences (PLSE) in Q1 2026: 265,164 shares worth $5.72M. The stake represents 0.01% of the portfolio and ranks #1308 among its holdings.

96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Balyasny Asset Management held 265,164 shares of Pulse Biosciences worth $5.72M as of Q1 2026.
  • Pulse Biosciences was a new Balyasny Asset Management position in Q1 2026.
  • Pulse Biosciences made up 0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1308 holding.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.